Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
US7276483B1 · kind B1 · utility
2Cited by
0References
4Claims
0Family size
Inventors
Key dates
| Filing date | Apr 8, 2004 |
| Grant date | Oct 2, 2007 |
| Priority date | — |
| Expiry date | Jul 28, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition, or pharmaceutical agent for treating Aβ amyloidosis in a patient that has at least one laminin-derived peptide or fragment thereof from the group D-A13, D-HA3G76, D-A4G82, D-A5G81, D-A5G101, D-HA3G47, D-HA3G58, D-HA3G74, D-HA3G83, D-A5G82, D-R-AG73, D-R-A13, D-R-HA3G76, D-R-A4G82, and D-R-A5G81.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.